COVID-19 pandemic has increased mental health burden on family and friends of patients

Family members and close friends of people with COVID-19 have elevated symptoms of depression and anxiety, a study from Karolinska Institutet published in The Lancet Regional Health – Europe reports.

Guidehealth, Story Health Partner to Deliver Value-Based Cardiology Care

Story Health Co-Founders Tom Stanis (CEO), Nita Sommers (President), Ashul Govil, MD MBA (Chief Medical Officer), Nikhil Roy (Chief Product Officer) What You Should Know: –

July 15, 2024

What are the potential long-term effects on healthcare and the economy due to decreased STEMI treatment during the COVID-19 pandemic?

Researchers predicted long-term health consequences and expenses associated with ST-elevation myocardial infarction (STEMI) treatment during the first COVID-19 lockdown.

June 20, 2023

Agios’ tebapivat gets FDA orphan drug designation

Agios focuses on developing groundbreaking therapies for patients with rare diseases. Credit: kiehlord/Shutterstock. Agios Pharmaceuticals has announced that the US Food and Drug Administration (FDA) has

September 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.